KALLMANN SYNDROME

  •  

    KALLMANN SYNDROME

     

    DEFINITION:

    An x-linked disorder characterized by a GnRH deficiency with hypogonadotropic hypogonadism and delayed puberty, and smelling deficiencies.

    EPIDEMIOLOGY:

    • incidence: 1/10,000 (M); 1/50,000 (F)
      • 1/25 in hyposmic or anosmic patients
      • 1/30 in 46, XY patients with hypogonadism
    • age of onset:
      • adolescence (with delayed puberty)
    • risk factors:
      • familial - x-linked recessive (also autosomal recessive and autosomal dominant forms)
      • chrom.#: Xp22.3
      • gene: ?
    • may be associated with other x-linked disorders
      • steroid sulfatase deficiency (x-linked ichthyosis)
      • Conradi Syndrome
    • M > F (5:1)

    PATHOGENESIS:

    1. Genetic Defect

    • genetic defect -> interference with the migration of GnRH-secreting cells arising from the nasal placode (precursor of the nose) to the hypothalamus during fetal life results in:
      • agenesis of the olfactory lobes -> smelling difficulties
      • GnRH deficiency -> decreased secretion of LH and FSH -> failure to develop secondary sexual characteristics
    • GnRH deficiency may be complete or partial
    • this disorder is considered to be a defect of the hypothalamus and not the pituitary (i.e., secondary hypogonadism)
    • genetic heterogeneity -> phenotypic heterogeneity

    CLINICAL FEATURES:

    1. Major

    • highly variable
      • anosmia -> hyposmia -> euosmia
      • hypogonadism -> normal gonads
      • lack of -> delayed -> normal development of secondary sexual characteristics

    2. Others

    1. Facial

    • choanal atresia
    • cleft palate +/- lip
    • hearing loss and deafness
    • hypotelorism
    • median facial clefts

    2. Genitourinary

    • renal anomalies (unilateral agenesis)
    • cryptorchidism in males
      • decreased spermatogenesis
      • increased risk of testicular tumors

    3. Neurologic

    • borderline to normal intelligence

    INVESTIGATIONS:

    1. Serum

    • low levels of testosterone (androgens)
    • prepubertal levels of LH and FSH
    • positive response to GnRH stimulation

    2. Imaging Studies

    1. MRI/CT

    • absent olfactory bulbs - unilateral or bilateral

    MANAGEMENT:

    1. Medical

    1. Hormonal Replacement

    • estrogen or testosterone
    • pulsatile GnRH or repeated hCG injections

    2. Supportive

    • psychological counselling
    • genetic counselling

    3. Prognosis

    • normal life span

     

     

    Pediatric Database - KALLMANN SYNDROME

    Pediatric Organization - Pedbase [at] Gmail.com